Search Results

Containing any of the words

Only of the type

A Phase 4, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Effectiveness and Safety of Tirzepatide Once Weekly in Adult Participants with Type 2 Diabetes during Ramadan (T-RAM) Drug Clinical Trial

Through the Conference Sessions & Accompanying Exhibition:SFDA Participates in the 2nd. National e-government Conference ”Yesser” News

A Randomized, Double-blind, Multicenter, Phase III Study of Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced NET of GI or Lung Origin - RADIANT-4 Drug Clinical Trial

"A Phase IIIb, Single-arm Study to Evaluate the Safety and Immunogenicity ofArabio Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 56Years and Above in Saudi Arabia" Drug Clinical Trial

"Prospective Observational Clinical Practice Study in the 1st LineManagement of mCRC with Erbitux ™ in combination with Chemotherapy" Drug Clinical Trial

An Open Label, Phase IV, Multi-Centric, Prospective, Single Arm Study to Assess the Safety and Efficacy of Dexaflox Eye Drops Containing Ofloxacin (3 mg) and dexamethasone (1 mg) in Subjects with Bacterial Conjunctivitis Drug Clinical Trial

A Phase IV Double-Blind Placebo-Controlled Randomized Clinical Trial Assessing the Effect of 2 month consumption of Vetal Laban Including Lactobacillus acidophilus NCFM on Functional Gastrointestinal Symptoms Among Subjects Fulfilling Rome III Criteria for A Phase IV, Randomized, double-blind, placebo-controlled study with parallel groups Irritable Bowel Syndrome Drug Clinical Trial

An open label, Phase IV, multicenter study to Assess the efficacy and safety of Elica-MTM Cream Containing Miconazole nitrate 2% w/w and Mometasone furoate 0.1% w/w) in Napkin Dermatitis with Inflamed Skin Conditions of Eczema or Dermatitis Caused by Infection With Certain Fungi and Bacteria Drug Clinical Trial

Psoriasis Study of Health Outcomes (PSoHO) – an International Observational Study of 3-Year Health Outcomes in the Biologic Treatment of Moderate-to-Severe Plaque Psoriasis Drug Clinical Trial

AWARE-AMAC (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation in Asia pacific, Middle-east and African Countries (AWARE-AMAC): A noninterventional study to collect data on the management and clinical impacts of chronic urticaria in patients refractory to H1-antihistamine therapy Drug Clinical Trial